$502 Million is the total value of Invus Financial Advisors, LLC's 8 reported holdings in Q2 2021. The portfolio turnover from Q1 2021 to Q2 2021 was 14.3% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| CPNG | Coupang Inccl a | $190,890,000 | -15.3% | 4,564,571 | 0.0% | 38.03% | -26.3% | |
| TBLA | New | Taboola.com Ltd | $81,409,000 | – | 7,865,610 | +100.0% | 16.22% | – |
| NVCR | Novocure Ltd | $77,833,000 | +67.8% | 350,884 | 0.0% | 15.51% | +45.9% | |
| RCUS | Arcus Biosciences Inc | $50,583,000 | -2.2% | 1,842,077 | 0.0% | 10.08% | -15.0% | |
| OYST | Oyster Point Pharma Inc | $47,592,000 | -6.0% | 2,768,586 | 0.0% | 9.48% | -18.2% | |
| YEXT | Yext Inc | $30,678,000 | -1.3% | 2,146,785 | 0.0% | 6.11% | -14.2% | |
| ORIC | Oric Pharmaceuticals Inc | $17,824,000 | -27.8% | 1,007,575 | 0.0% | 3.55% | -37.2% | |
| UBX | Unity Biotechnology Inc | $5,081,000 | -22.7% | 1,094,998 | 0.0% | 1.01% | -32.8% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-08-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Arcus Biosciences Inc | 16 | Q3 2023 | 24.7% |
| Novocure Ltd | 16 | Q3 2023 | 25.4% |
| Oric Pharmaceuticals Inc | 14 | Q3 2023 | 14.3% |
| Oyster Point Pharma Inc | 13 | Q4 2022 | 44.5% |
| Coupang Inc | 11 | Q3 2023 | 51.6% |
| Taboola.com Ltd | 10 | Q3 2023 | 23.7% |
| Unity Biotechnology Inc | 9 | Q4 2021 | 8.0% |
| Yext Inc | 8 | Q3 2021 | 30.3% |
| IONQ Inc | 8 | Q3 2023 | 7.2% |
| Nu Hldgs Ltd | 6 | Q3 2023 | 25.4% |
View Invus Financial Advisors, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Invus Financial Advisors, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.